Home
About Us
Events
Contact Us
END OF DAY 1 AND NETWORKING DRINKS
Post navigation
Previous:
PSI’s VISIONAL: Enhancing Feasibility & Enrollment Predictions with GenAI
Next:
PANEL DISCUSSION: Innovatively progressing patient-centric oncology trials in 2025
